Gene: SATB2
Official Full Name: SATB homeobox 2provided by HGNC
Gene Summary: This gene encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. The encoded protein is involved in transcription regulation and chromatin remodeling. Defects in this gene are associated with isolated cleft palate and cognitive disability. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29452 | SATB2 Knockout cell line (HeLa) | Human | SATB2 | 1:3~1:6 | Negative | Online Inquiry |
KO29453 | SATB2 Knockout cell line (HCT 116) | Human | SATB2 | 1:2~1:4 | Negative | Online Inquiry |
KO29454 | SATB2 Knockout cell line (HEK293) | Human | SATB2 | 1:3~1:6 | Negative | Online Inquiry |
KO29455 | SATB2 Knockout cell line (A549) | Human | SATB2 | 1:3~1:4 | Negative | Online Inquiry |
SATB2 Gene Knockout Cell Lines are specialized cellular models engineered to lack the SATB2 gene, a critical regulator involved in developmental processes and gene expression. These knockout cell lines serve as invaluable tools for dissecting the functional role of SATB2 in various biological contexts, including its involvement in skeletal development, neurogenesis, and cellular signaling pathways.
The primary function of SATB2 is to act as a chromatin organizer, influencing the three-dimensional architecture of the genome and regulating the transcription of key developmental genes. By utilizing these knockout cell lines, researchers can gain insights into the molecular mechanisms underlying SATB2’s function and its contribution to disease states, particularly in conditions like cleft palate, cognitive impairments, and certain cancers. The absence of SATB2 allows for the modeling of these defects, facilitating a better understanding of the gene's role in pathophysiology.
From a scientific perspective, SATB2 Gene Knockout Cell Lines have significant applications in both basic and translational research. They are crucial for studying gene function in developmental biology, screening potential drug targets, and exploring gene-environment interactions. Their ability to mimic physiological conditions makes them ideal for high-throughput screening in pharmaceutical research and for validating therapeutic strategies aimed at targeting SATB2-associated pathways.
One of the unique advantages of our SATB2 Gene Knockout Cell Lines is their generation through optimized CRISPR-Cas9 technology, ensuring high specificity and efficiency in gene disruption. This is a considerable improvement over traditional knockout methods which may lead to off-target effects or incomplete knockout phenotypes. Furthermore, these cell lines are validated for key markers and developmental pathways, providing researchers with robust and reproducible experimental models.
For researchers and clinicians engaged in a range of genetic, developmental, or oncological studies, our SATB2 Gene Knockout Cell Lines represent a critical resource for advancing knowledge and developing innovative therapies. With extensive expertise in genetic engineering and a commitment to high-quality biological products, our company is dedicated to providing the research community with cutting-edge tools to propel scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.